CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for inVentiv Health Clinical, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

inVentiv Health Clinical, Inc.
470 Altantic Ave., 11th Floor
Boston, MA  02210  United States

This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company

Business Summary
inVentiv Health Clinical, Inc., formerly known as PharmaNet Development Group Inc., is a global developer of drug services for pharmaceutical, biotechnology, generic drug, and medical device companies of all sizes. The Company operates as a division of inVentiv Health Inc., a provider of outsourced clinical development and commercialization services to biopharmaceutical companies.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
IRA CQ
Score
Moody's
Rating
Fitch
Rating
DBRS
Rating
Morningstar
Rating
-Yes-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/200812/31/2008YesYes--Yes

Industries
SIC Code Description
8731 Commercial physical and biological research

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
President, Chief Executive Officer, Director Jeffrey P.McMullen 57 3/1/2006 12/1/2004
Chief Financial Officer, Executive Vice President John P.Hamill 45 8/1/2006 8/1/2006
Executive Vice President; President - Late Stage Development Thomas J.Newman 60 2/1/2008 8/24/2006
6 additional Officers and Directors records available in full report.

Business Names
Business Name
Anapharm Europe S.L.
Anapharm, Inc.
Beijing PharmaNet Medical & Drug Science and Technology Company Limited
15 additional Business Names available in full report.

General Information
Stock Exchange: NASD
Federal Tax Id: 592407464


Copyright © 2019 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, October 24, 2019